Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-11

Clinical Trial Update: Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reports completion of a study evaluating natural killer cell therapy in adults with acute myeloid leukemia, including patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Natural Killer cell therapy (natural killer cell therapy)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML, Adult, Minimal Residual Disease | Phase 1 | Status: COMPLETED